Skip to content

The Efficacy of Modified Haitongpi Decoction Fumigation Therapy in the Treatment of Frozen Shoulder Based on Targeted Exercise

The Efficacy of Modified Haitongpi Decoction Fumigation Therapy in the Treatment of Frozen Shoulder Based on Targeted Exercise

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000102
Enrollment
Unknown
Registered
2026-01-17
Start date
2022-07-22
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frozen shoulder

Interventions

Content Group 2:Application of traditional Chinese medicine fumigation therapy combined with targeted exercise therapy
Control Group:The sole application of Chinese herbal steam therapy.

Sponsors

Yiwu Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: The diagnosis of FS was made in accordance with the criteria specified in the 5th edition of Rehabilitation Medicine, a national planning textbook for the "12th Five-Year Plan" issued by the National Health and Family Planning Commission. The inclusion criteria were as follows: patients aged around 50 years (ranging from 40 to 70 years); no specific treatment administered to the affected shoulder within one month prior to enrollment; no severe systemic diseases such as cardio-cerebrovascular or renal disorders; no coagulation system disorders; no cardiac pacemaker implantation history. All participants signed an informed consent form and were able to actively cooperate with the treatment and follow-up observations.

Exclusion criteria

Exclusion criteria: Patients with mental disorders; patients with shoulder pain caused by comorbidities or other diseases; patients who have received anticoagulant therapy within 4 weeks; patients with untreated cardio-cerebrovascular diseases who cannot tolerate stimulation therapy; patients who develop severe adverse reactions such as local skin damage during treatment.

Design outcomes

Primary

MeasureTime frame
Shoulder Joint VAS Pain Score;

Secondary

MeasureTime frame
Range of Motion (ROM);Efficacy Assessment;

Countries

China

Contacts

Public ContactWu Guolin

Yiwu Central Hospital

wuguolin221221@163.com13665820885

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 7, 2026